- GlobeNewswire•6 days ago
Santhera becomes Founding Member of the Industry Advisory Council of the United Mitochondrial Disease Foundation
Liestal, Switzerland, April 25, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces Jodi Wolff, PhD, to represent Santhera as a founding member of the United Mitochondrial Disease Foundation (UMDF) Industry ...
- GlobeNewswire•26 days ago
Liestal, Switzerland, April 4, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that a large majority of shareholders approved all proposals by the Board of Directors at the Annual Shareholders` Meeting ...
- GlobeNewswire•2 months ago
Liestal, Switzerland, March 7, 2017 - Santhera Pharmaceuticals (SIX: SANN) reports the Group`s audited financial results for 2016. The Company generated net revenues of CHF 19.0 million (+340% year-on-year) ...
SANN.SW : Summary for SANTHERA N - Yahoo Finance
Santhera Pharmaceuticals Holding AG (SANN.SW)
Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
|Day's Range||71.50 - 72.95|
|52 Week Range||37.05 - 86.35|
|PE Ratio (TTM)||-12.65|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|